nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine triphosphate—ABCC9—uterine cancer	0.382	0.668	CbGaD
Adenosine triphosphate—AKT1—uterine cancer	0.189	0.331	CbGaD
Adenosine triphosphate—ABCB11—Progesterone—uterine cancer	0.0761	0.414	CbGbCtD
Adenosine triphosphate—ABCB11—Doxorubicin—uterine cancer	0.0232	0.126	CbGbCtD
Adenosine triphosphate—ABCC2—Carboplatin—uterine cancer	0.0213	0.116	CbGbCtD
Adenosine triphosphate—ABCC2—Etoposide—uterine cancer	0.0179	0.0973	CbGbCtD
Adenosine triphosphate—ABCB1—Progesterone—uterine cancer	0.013	0.0709	CbGbCtD
Adenosine triphosphate—ABCC2—Doxorubicin—uterine cancer	0.0122	0.0664	CbGbCtD
Adenosine triphosphate—ABCB1—Dactinomycin—uterine cancer	0.0103	0.0562	CbGbCtD
Adenosine triphosphate—ABCB1—Etoposide—uterine cancer	0.00584	0.0317	CbGbCtD
Adenosine triphosphate—ABCB1—Doxorubicin—uterine cancer	0.00398	0.0216	CbGbCtD
Adenosine triphosphate—ABCG1—decidua—uterine cancer	0.000664	0.00582	CbGeAlD
Adenosine triphosphate—ACVRL1—decidua—uterine cancer	0.000664	0.00582	CbGeAlD
Adenosine triphosphate—NAE1—Levonorgestrel—Progesterone—uterine cancer	0.000659	0.209	CbGdCrCtD
Adenosine triphosphate—HSPA1A—uterine cervix—uterine cancer	0.00065	0.0057	CbGeAlD
Adenosine triphosphate—HSPA1B—uterine cervix—uterine cancer	0.00065	0.0057	CbGeAlD
Adenosine triphosphate—ABCC9—smooth muscle tissue—uterine cancer	0.000644	0.00565	CbGeAlD
Adenosine triphosphate—HSPA1A—smooth muscle tissue—uterine cancer	0.000632	0.00554	CbGeAlD
Adenosine triphosphate—ABCG1—endometrium—uterine cancer	0.00063	0.00553	CbGeAlD
Adenosine triphosphate—HSPA1B—decidua—uterine cancer	0.000619	0.00543	CbGeAlD
Adenosine triphosphate—HSPA1A—decidua—uterine cancer	0.000619	0.00543	CbGeAlD
Adenosine triphosphate—ACVRL1—mammalian vulva—uterine cancer	0.00061	0.00535	CbGeAlD
Adenosine triphosphate—ABCG1—mammalian vulva—uterine cancer	0.00061	0.00535	CbGeAlD
Adenosine triphosphate—ARAF—uterine cervix—uterine cancer	0.000608	0.00533	CbGeAlD
Adenosine triphosphate—ACVR1B—uterine cervix—uterine cancer	0.00059	0.00518	CbGeAlD
Adenosine triphosphate—HSPA1A—endometrium—uterine cancer	0.000588	0.00516	CbGeAlD
Adenosine triphosphate—HSPA1B—endometrium—uterine cancer	0.000588	0.00516	CbGeAlD
Adenosine triphosphate—ACSS1—myometrium—uterine cancer	0.000583	0.00512	CbGeAlD
Adenosine triphosphate—ACVRL1—uterus—uterine cancer	0.000581	0.00509	CbGeAlD
Adenosine triphosphate—ABCG1—uterus—uterine cancer	0.000581	0.00509	CbGeAlD
Adenosine triphosphate—ARAF—decidua—uterine cancer	0.000579	0.00508	CbGeAlD
Adenosine triphosphate—ADRBK2—female reproductive system—uterine cancer	0.000575	0.00505	CbGeAlD
Adenosine triphosphate—NT5C2—myometrium—uterine cancer	0.000571	0.00501	CbGeAlD
Adenosine triphosphate—ACVR1—myometrium—uterine cancer	0.000571	0.00501	CbGeAlD
Adenosine triphosphate—ASNA1—uterine cervix—uterine cancer	0.00057	0.005	CbGeAlD
Adenosine triphosphate—ARAF—renal system—uterine cancer	0.000569	0.00499	CbGeAlD
Adenosine triphosphate—HSPA1B—mammalian vulva—uterine cancer	0.000569	0.00499	CbGeAlD
Adenosine triphosphate—HSPA1A—mammalian vulva—uterine cancer	0.000569	0.00499	CbGeAlD
Adenosine triphosphate—AFG3L2—uterine cervix—uterine cancer	0.000563	0.00494	CbGeAlD
Adenosine triphosphate—ACSS2—myometrium—uterine cancer	0.000559	0.0049	CbGeAlD
Adenosine triphosphate—ACSL1—myometrium—uterine cancer	0.000556	0.00487	CbGeAlD
Adenosine triphosphate—ASNA1—smooth muscle tissue—uterine cancer	0.000554	0.00486	CbGeAlD
Adenosine triphosphate—ACVR1B—renal system—uterine cancer	0.000552	0.00484	CbGeAlD
Adenosine triphosphate—ARAF—endometrium—uterine cancer	0.00055	0.00482	CbGeAlD
Adenosine triphosphate—NAE1—uterine cervix—uterine cancer	0.000549	0.00482	CbGeAlD
Adenosine triphosphate—ASNA1—decidua—uterine cancer	0.000544	0.00477	CbGeAlD
Adenosine triphosphate—HSPA1B—uterus—uterine cancer	0.000542	0.00475	CbGeAlD
Adenosine triphosphate—HSPA1A—uterus—uterine cancer	0.000542	0.00475	CbGeAlD
Adenosine triphosphate—NAE1—smooth muscle tissue—uterine cancer	0.000534	0.00468	CbGeAlD
Adenosine triphosphate—ASNA1—renal system—uterine cancer	0.000534	0.00468	CbGeAlD
Adenosine triphosphate—AFG3L2—renal system—uterine cancer	0.000527	0.00462	CbGeAlD
Adenosine triphosphate—ADRBK2—female gonad—uterine cancer	0.000524	0.00459	CbGeAlD
Adenosine triphosphate—NAE1—decidua—uterine cancer	0.000524	0.00459	CbGeAlD
Adenosine triphosphate—ACVRL1—female reproductive system—uterine cancer	0.000522	0.00458	CbGeAlD
Adenosine triphosphate—ADRBK2—vagina—uterine cancer	0.00052	0.00456	CbGeAlD
Adenosine triphosphate—ASNA1—endometrium—uterine cancer	0.000516	0.00453	CbGeAlD
Adenosine triphosphate—NAE1—renal system—uterine cancer	0.000514	0.00451	CbGeAlD
Adenosine triphosphate—AFG3L2—endometrium—uterine cancer	0.000509	0.00447	CbGeAlD
Adenosine triphosphate—ARAF—uterus—uterine cancer	0.000507	0.00444	CbGeAlD
Adenosine triphosphate—ASNA1—mammalian vulva—uterine cancer	0.000499	0.00438	CbGeAlD
Adenosine triphosphate—NAE1—endometrium—uterine cancer	0.000497	0.00436	CbGeAlD
Adenosine triphosphate—AMHR2—lymph node—uterine cancer	0.000496	0.00435	CbGeAlD
Adenosine triphosphate—AFG3L2—mammalian vulva—uterine cancer	0.000493	0.00432	CbGeAlD
Adenosine triphosphate—SLC25A4—decidua—uterine cancer	0.000488	0.00428	CbGeAlD
Adenosine triphosphate—NAE1—mammalian vulva—uterine cancer	0.000481	0.00422	CbGeAlD
Adenosine triphosphate—ASNS—myometrium—uterine cancer	0.00048	0.00421	CbGeAlD
Adenosine triphosphate—AKT1—myometrium—uterine cancer	0.00048	0.00421	CbGeAlD
Adenosine triphosphate—APAF1—lymph node—uterine cancer	0.000479	0.0042	CbGeAlD
Adenosine triphosphate—SLC25A4—renal system—uterine cancer	0.000479	0.0042	CbGeAlD
Adenosine triphosphate—TNK2—decidua—uterine cancer	0.000478	0.00419	CbGeAlD
Adenosine triphosphate—ASNA1—uterus—uterine cancer	0.000475	0.00417	CbGeAlD
Adenosine triphosphate—ABCG1—female gonad—uterine cancer	0.000475	0.00417	CbGeAlD
Adenosine triphosphate—ABCG1—vagina—uterine cancer	0.000472	0.00414	CbGeAlD
Adenosine triphosphate—ACVRL1—vagina—uterine cancer	0.000472	0.00414	CbGeAlD
Adenosine triphosphate—AFG3L2—uterus—uterine cancer	0.000469	0.00412	CbGeAlD
Adenosine triphosphate—NAE1—uterus—uterine cancer	0.000458	0.00402	CbGeAlD
Adenosine triphosphate—ARAF—female reproductive system—uterine cancer	0.000456	0.004	CbGeAlD
Adenosine triphosphate—ACSS1—uterine cervix—uterine cancer	0.000454	0.00398	CbGeAlD
Adenosine triphosphate—ABCC9—female gonad—uterine cancer	0.000452	0.00396	CbGeAlD
Adenosine triphosphate—NT5C2—uterine cervix—uterine cancer	0.000444	0.0039	CbGeAlD
Adenosine triphosphate—ACVR1—uterine cervix—uterine cancer	0.000444	0.0039	CbGeAlD
Adenosine triphosphate—HSPA1B—female gonad—uterine cancer	0.000443	0.00389	CbGeAlD
Adenosine triphosphate—HSPA1A—female gonad—uterine cancer	0.000443	0.00389	CbGeAlD
Adenosine triphosphate—ACVR1B—female reproductive system—uterine cancer	0.000442	0.00388	CbGeAlD
Adenosine triphosphate—ADRBK1—smooth muscle tissue—uterine cancer	0.000441	0.00387	CbGeAlD
Adenosine triphosphate—HSPA1A—vagina—uterine cancer	0.000441	0.00386	CbGeAlD
Adenosine triphosphate—HSPA1B—vagina—uterine cancer	0.000441	0.00386	CbGeAlD
Adenosine triphosphate—ACSS2—uterine cervix—uterine cancer	0.000435	0.00382	CbGeAlD
Adenosine triphosphate—ACSS1—decidua—uterine cancer	0.000432	0.00379	CbGeAlD
Adenosine triphosphate—ACSL1—uterine cervix—uterine cancer	0.000432	0.00379	CbGeAlD
Adenosine triphosphate—NT5C2—smooth muscle tissue—uterine cancer	0.000432	0.00379	CbGeAlD
Adenosine triphosphate—ABCA1—decidua—uterine cancer	0.000428	0.00375	CbGeAlD
Adenosine triphosphate—ASNA1—female reproductive system—uterine cancer	0.000427	0.00375	CbGeAlD
Adenosine triphosphate—ADRBK1—renal system—uterine cancer	0.000425	0.00372	CbGeAlD
Adenosine triphosphate—ACSS1—renal system—uterine cancer	0.000425	0.00372	CbGeAlD
Adenosine triphosphate—NT5C2—decidua—uterine cancer	0.000423	0.00371	CbGeAlD
Adenosine triphosphate—ACVR1—decidua—uterine cancer	0.000423	0.00371	CbGeAlD
Adenosine triphosphate—AFG3L2—female reproductive system—uterine cancer	0.000422	0.0037	CbGeAlD
Adenosine triphosphate—ABCA1—renal system—uterine cancer	0.00042	0.00368	CbGeAlD
Adenosine triphosphate—TNK2—uterus—uterine cancer	0.000418	0.00367	CbGeAlD
Adenosine triphosphate—ASS1—myometrium—uterine cancer	0.000418	0.00367	CbGeAlD
Adenosine triphosphate—ACVR1—renal system—uterine cancer	0.000416	0.00364	CbGeAlD
Adenosine triphosphate—NT5C2—renal system—uterine cancer	0.000416	0.00364	CbGeAlD
Adenosine triphosphate—ACSS2—decidua—uterine cancer	0.000415	0.00364	CbGeAlD
Adenosine triphosphate—ARAF—female gonad—uterine cancer	0.000415	0.00364	CbGeAlD
Adenosine triphosphate—ARAF—vagina—uterine cancer	0.000412	0.00361	CbGeAlD
Adenosine triphosphate—ACSL1—decidua—uterine cancer	0.000412	0.00361	CbGeAlD
Adenosine triphosphate—NAE1—female reproductive system—uterine cancer	0.000412	0.00361	CbGeAlD
Adenosine triphosphate—ACSS1—endometrium—uterine cancer	0.000411	0.0036	CbGeAlD
Adenosine triphosphate—PRKAA1—uterine cervix—uterine cancer	0.000409	0.00359	CbGeAlD
Adenosine triphosphate—ACSS2—renal system—uterine cancer	0.000407	0.00357	CbGeAlD
Adenosine triphosphate—ACSL1—renal system—uterine cancer	0.000404	0.00355	CbGeAlD
Adenosine triphosphate—ACVR1B—female gonad—uterine cancer	0.000402	0.00353	CbGeAlD
Adenosine triphosphate—NT5C2—endometrium—uterine cancer	0.000402	0.00352	CbGeAlD
Adenosine triphosphate—ACVR1—endometrium—uterine cancer	0.000402	0.00352	CbGeAlD
Adenosine triphosphate—ACSS1—mammalian vulva—uterine cancer	0.000397	0.00348	CbGeAlD
Adenosine triphosphate—ACSS2—endometrium—uterine cancer	0.000394	0.00345	CbGeAlD
Adenosine triphosphate—ALK—female reproductive system—uterine cancer	0.000391	0.00343	CbGeAlD
Adenosine triphosphate—ACSL1—endometrium—uterine cancer	0.000391	0.00343	CbGeAlD
Adenosine triphosphate—ASNA1—female gonad—uterine cancer	0.000389	0.00341	CbGeAlD
Adenosine triphosphate—NT5C2—mammalian vulva—uterine cancer	0.000389	0.00341	CbGeAlD
Adenosine triphosphate—ACVR1—mammalian vulva—uterine cancer	0.000389	0.00341	CbGeAlD
Adenosine triphosphate—ASNA1—vagina—uterine cancer	0.000387	0.00339	CbGeAlD
Adenosine triphosphate—AFG3L2—female gonad—uterine cancer	0.000384	0.00337	CbGeAlD
Adenosine triphosphate—SLC25A4—female reproductive system—uterine cancer	0.000383	0.00336	CbGeAlD
Adenosine triphosphate—PRKAA1—renal system—uterine cancer	0.000383	0.00336	CbGeAlD
Adenosine triphosphate—AFG3L2—vagina—uterine cancer	0.000382	0.00335	CbGeAlD
Adenosine triphosphate—ACSS2—mammalian vulva—uterine cancer	0.000381	0.00334	CbGeAlD
Adenosine triphosphate—ACSL1—mammalian vulva—uterine cancer	0.000378	0.00332	CbGeAlD
Adenosine triphosphate—AKT1—epithelium—uterine cancer	0.000377	0.0033	CbGeAlD
Adenosine triphosphate—TNK2—female reproductive system—uterine cancer	0.000376	0.0033	CbGeAlD
Adenosine triphosphate—NAE1—female gonad—uterine cancer	0.000375	0.00329	CbGeAlD
Adenosine triphosphate—ASNS—uterine cervix—uterine cancer	0.000373	0.00327	CbGeAlD
Adenosine triphosphate—AKT1—uterine cervix—uterine cancer	0.000373	0.00327	CbGeAlD
Adenosine triphosphate—NAE1—vagina—uterine cancer	0.000372	0.00327	CbGeAlD
Adenosine triphosphate—NT5C2—uterus—uterine cancer	0.00037	0.00325	CbGeAlD
Adenosine triphosphate—ACVR1—uterus—uterine cancer	0.00037	0.00325	CbGeAlD
Adenosine triphosphate—ADK—myometrium—uterine cancer	0.000365	0.0032	CbGeAlD
Adenosine triphosphate—ASNS—smooth muscle tissue—uterine cancer	0.000363	0.00318	CbGeAlD
Adenosine triphosphate—AKT1—smooth muscle tissue—uterine cancer	0.000363	0.00318	CbGeAlD
Adenosine triphosphate—ACSS2—uterus—uterine cancer	0.000363	0.00318	CbGeAlD
Adenosine triphosphate—HSPA1A—Podofilox—Etoposide—uterine cancer	0.000362	0.115	CbGdCrCtD
Adenosine triphosphate—ACSL1—uterus—uterine cancer	0.00036	0.00316	CbGeAlD
Adenosine triphosphate—AKT1—decidua—uterine cancer	0.000356	0.00312	CbGeAlD
Adenosine triphosphate—ASNS—decidua—uterine cancer	0.000356	0.00312	CbGeAlD
Adenosine triphosphate—AKT1—renal system—uterine cancer	0.000349	0.00306	CbGeAlD
Adenosine triphosphate—SLC25A4—female gonad—uterine cancer	0.000349	0.00306	CbGeAlD
Adenosine triphosphate—SLC25A4—vagina—uterine cancer	0.000347	0.00304	CbGeAlD
Adenosine triphosphate—TNK2—female gonad—uterine cancer	0.000342	0.003	CbGeAlD
Adenosine triphosphate—ADRBK1—female reproductive system—uterine cancer	0.00034	0.00298	CbGeAlD
Adenosine triphosphate—ACSS1—female reproductive system—uterine cancer	0.00034	0.00298	CbGeAlD
Adenosine triphosphate—AKT1—endometrium—uterine cancer	0.000338	0.00296	CbGeAlD
Adenosine triphosphate—ASNS—endometrium—uterine cancer	0.000338	0.00296	CbGeAlD
Adenosine triphosphate—ADRBK2—lymph node—uterine cancer	0.000337	0.00295	CbGeAlD
Adenosine triphosphate—ABCA1—female reproductive system—uterine cancer	0.000336	0.00295	CbGeAlD
Adenosine triphosphate—NT5C2—female reproductive system—uterine cancer	0.000333	0.00292	CbGeAlD
Adenosine triphosphate—ACVR1—female reproductive system—uterine cancer	0.000333	0.00292	CbGeAlD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Medroxyprogesterone Acetate—uterine cancer	0.000332	0.105	CbGdCrCtD
Adenosine triphosphate—ASS1—epithelium—uterine cancer	0.000328	0.00288	CbGeAlD
Adenosine triphosphate—AKT1—mammalian vulva—uterine cancer	0.000327	0.00287	CbGeAlD
Adenosine triphosphate—ASNS—mammalian vulva—uterine cancer	0.000327	0.00287	CbGeAlD
Adenosine triphosphate—ACSS2—female reproductive system—uterine cancer	0.000326	0.00286	CbGeAlD
Adenosine triphosphate—ASS1—uterine cervix—uterine cancer	0.000326	0.00286	CbGeAlD
Adenosine triphosphate—ACSL1—female reproductive system—uterine cancer	0.000324	0.00284	CbGeAlD
Adenosine triphosphate—ASS1—smooth muscle tissue—uterine cancer	0.000316	0.00277	CbGeAlD
Adenosine triphosphate—AKT1—uterus—uterine cancer	0.000311	0.00273	CbGeAlD
Adenosine triphosphate—ASNS—uterus—uterine cancer	0.000311	0.00273	CbGeAlD
Adenosine triphosphate—ASS1—decidua—uterine cancer	0.00031	0.00272	CbGeAlD
Adenosine triphosphate—ADRBK1—female gonad—uterine cancer	0.000309	0.00271	CbGeAlD
Adenosine triphosphate—ACSS1—female gonad—uterine cancer	0.000309	0.00271	CbGeAlD
Adenosine triphosphate—ADRBK1—vagina—uterine cancer	0.000308	0.0027	CbGeAlD
Adenosine triphosphate—ACSS1—vagina—uterine cancer	0.000308	0.0027	CbGeAlD
Adenosine triphosphate—PRKAA1—female reproductive system—uterine cancer	0.000307	0.00269	CbGeAlD
Adenosine triphosphate—ABCA1—female gonad—uterine cancer	0.000306	0.00268	CbGeAlD
Adenosine triphosphate—ACVRL1—lymph node—uterine cancer	0.000305	0.00268	CbGeAlD
Adenosine triphosphate—ABCG1—lymph node—uterine cancer	0.000305	0.00268	CbGeAlD
Adenosine triphosphate—ASS1—renal system—uterine cancer	0.000305	0.00267	CbGeAlD
Adenosine triphosphate—ABCA1—vagina—uterine cancer	0.000304	0.00267	CbGeAlD
Adenosine triphosphate—ACVR1—female gonad—uterine cancer	0.000303	0.00266	CbGeAlD
Adenosine triphosphate—NT5C2—female gonad—uterine cancer	0.000303	0.00266	CbGeAlD
Adenosine triphosphate—NT5C2—vagina—uterine cancer	0.000301	0.00264	CbGeAlD
Adenosine triphosphate—ACVR1—vagina—uterine cancer	0.000301	0.00264	CbGeAlD
Adenosine triphosphate—ACSS2—female gonad—uterine cancer	0.000297	0.0026	CbGeAlD
Adenosine triphosphate—ADCY1—lymph node—uterine cancer	0.000296	0.0026	CbGeAlD
Adenosine triphosphate—ACSS2—vagina—uterine cancer	0.000295	0.00259	CbGeAlD
Adenosine triphosphate—ACSL1—female gonad—uterine cancer	0.000295	0.00259	CbGeAlD
Adenosine triphosphate—ASS1—endometrium—uterine cancer	0.000294	0.00258	CbGeAlD
Adenosine triphosphate—ACSL1—vagina—uterine cancer	0.000293	0.00257	CbGeAlD
Adenosine triphosphate—ABCC9—lymph node—uterine cancer	0.00029	0.00255	CbGeAlD
Adenosine triphosphate—ABL2—female gonad—uterine cancer	0.000289	0.00254	CbGeAlD
Adenosine triphosphate—ABL2—vagina—uterine cancer	0.000287	0.00252	CbGeAlD
Adenosine triphosphate—HSPA1A—lymph node—uterine cancer	0.000285	0.0025	CbGeAlD
Adenosine triphosphate—HSPA1B—lymph node—uterine cancer	0.000285	0.0025	CbGeAlD
Adenosine triphosphate—ASS1—mammalian vulva—uterine cancer	0.000285	0.0025	CbGeAlD
Adenosine triphosphate—ADK—uterine cervix—uterine cancer	0.000284	0.00249	CbGeAlD
Adenosine triphosphate—AKT1—female reproductive system—uterine cancer	0.00028	0.00245	CbGeAlD
Adenosine triphosphate—PRKAA1—female gonad—uterine cancer	0.000279	0.00245	CbGeAlD
Adenosine triphosphate—ADK—smooth muscle tissue—uterine cancer	0.000276	0.00242	CbGeAlD
Adenosine triphosphate—ASS1—uterus—uterine cancer	0.000271	0.00238	CbGeAlD
Adenosine triphosphate—ADK—decidua—uterine cancer	0.000271	0.00238	CbGeAlD
Adenosine triphosphate—ARAF—lymph node—uterine cancer	0.000267	0.00234	CbGeAlD
Adenosine triphosphate—ADK—renal system—uterine cancer	0.000266	0.00233	CbGeAlD
Adenosine triphosphate—ABL1—myometrium—uterine cancer	0.000263	0.00231	CbGeAlD
Adenosine triphosphate—ACVR1B—lymph node—uterine cancer	0.000259	0.00227	CbGeAlD
Adenosine triphosphate—ADK—endometrium—uterine cancer	0.000257	0.00225	CbGeAlD
Adenosine triphosphate—ABCC8—smooth muscle tissue—uterine cancer	0.000256	0.00225	CbGeAlD
Adenosine triphosphate—AKT1—female gonad—uterine cancer	0.000255	0.00223	CbGeAlD
Adenosine triphosphate—ASNS—female gonad—uterine cancer	0.000255	0.00223	CbGeAlD
Adenosine triphosphate—ASNS—vagina—uterine cancer	0.000253	0.00222	CbGeAlD
Adenosine triphosphate—AKT1—vagina—uterine cancer	0.000253	0.00222	CbGeAlD
Adenosine triphosphate—ASNA1—lymph node—uterine cancer	0.00025	0.00219	CbGeAlD
Adenosine triphosphate—ASS1—Norethindrone—Progesterone—uterine cancer	0.00025	0.0791	CbGdCrCtD
Adenosine triphosphate—ADK—mammalian vulva—uterine cancer	0.000249	0.00218	CbGeAlD
Adenosine triphosphate—AFG3L2—lymph node—uterine cancer	0.000247	0.00216	CbGeAlD
Adenosine triphosphate—ABCC8—renal system—uterine cancer	0.000247	0.00216	CbGeAlD
Adenosine triphosphate—ASS1—female reproductive system—uterine cancer	0.000244	0.00214	CbGeAlD
Adenosine triphosphate—NAE1—lymph node—uterine cancer	0.000241	0.00211	CbGeAlD
Adenosine triphosphate—ABCC8—endometrium—uterine cancer	0.000238	0.00209	CbGeAlD
Adenosine triphosphate—ALK—lymph node—uterine cancer	0.000229	0.00201	CbGeAlD
Adenosine triphosphate—SLC25A4—lymph node—uterine cancer	0.000224	0.00197	CbGeAlD
Adenosine triphosphate—ASS1—female gonad—uterine cancer	0.000222	0.00195	CbGeAlD
Adenosine triphosphate—ASS1—vagina—uterine cancer	0.000221	0.00193	CbGeAlD
Adenosine triphosphate—TNK2—lymph node—uterine cancer	0.00022	0.00193	CbGeAlD
Adenosine triphosphate—ADK—female reproductive system—uterine cancer	0.000213	0.00187	CbGeAlD
Adenosine triphosphate—ABL1—uterine cervix—uterine cancer	0.000205	0.00179	CbGeAlD
Adenosine triphosphate—ADRBK1—lymph node—uterine cancer	0.000199	0.00174	CbGeAlD
Adenosine triphosphate—ACSS1—lymph node—uterine cancer	0.000199	0.00174	CbGeAlD
Adenosine triphosphate—ABL1—smooth muscle tissue—uterine cancer	0.000199	0.00174	CbGeAlD
Adenosine triphosphate—ABCA1—lymph node—uterine cancer	0.000197	0.00173	CbGeAlD
Adenosine triphosphate—ABL1—decidua—uterine cancer	0.000195	0.00171	CbGeAlD
Adenosine triphosphate—NT5C2—lymph node—uterine cancer	0.000195	0.00171	CbGeAlD
Adenosine triphosphate—ACVR1—lymph node—uterine cancer	0.000195	0.00171	CbGeAlD
Adenosine triphosphate—ADK—female gonad—uterine cancer	0.000194	0.0017	CbGeAlD
Adenosine triphosphate—ADK—vagina—uterine cancer	0.000193	0.00169	CbGeAlD
Adenosine triphosphate—ABL1—renal system—uterine cancer	0.000191	0.00168	CbGeAlD
Adenosine triphosphate—ACSS2—lymph node—uterine cancer	0.000191	0.00167	CbGeAlD
Adenosine triphosphate—ACSL1—lymph node—uterine cancer	0.000189	0.00166	CbGeAlD
Adenosine triphosphate—HSPA1A—Idarubicin—Epirubicin—uterine cancer	0.000189	0.0598	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Daunorubicin—Epirubicin—uterine cancer	0.000189	0.0598	CbGdCrCtD
Adenosine triphosphate—ABL2—lymph node—uterine cancer	0.000186	0.00163	CbGeAlD
Adenosine triphosphate—ABL1—endometrium—uterine cancer	0.000185	0.00162	CbGeAlD
Adenosine triphosphate—PRKAA1—lymph node—uterine cancer	0.000179	0.00157	CbGeAlD
Adenosine triphosphate—ABL1—mammalian vulva—uterine cancer	0.000179	0.00157	CbGeAlD
Adenosine triphosphate—HSPA1A—Daunorubicin—Doxorubicin—uterine cancer	0.000175	0.0554	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Idarubicin—Doxorubicin—uterine cancer	0.000175	0.0554	CbGdCrCtD
Adenosine triphosphate—ABL1—uterus—uterine cancer	0.000171	0.0015	CbGeAlD
Adenosine triphosphate—ABCC2—renal system—uterine cancer	0.000166	0.00145	CbGeAlD
Adenosine triphosphate—ASNS—lymph node—uterine cancer	0.000164	0.00144	CbGeAlD
Adenosine triphosphate—AKT1—lymph node—uterine cancer	0.000164	0.00144	CbGeAlD
Adenosine triphosphate—ABL1—female reproductive system—uterine cancer	0.000153	0.00134	CbGeAlD
Adenosine triphosphate—ABL1—Idarubicin—Epirubicin—uterine cancer	0.000143	0.0453	CbGdCrCtD
Adenosine triphosphate—ABL1—Daunorubicin—Epirubicin—uterine cancer	0.000143	0.0453	CbGdCrCtD
Adenosine triphosphate—ABL1—Doxorubicin—Epirubicin—uterine cancer	0.000143	0.0453	CbGdCrCtD
Adenosine triphosphate—ASS1—lymph node—uterine cancer	0.000143	0.00125	CbGeAlD
Adenosine triphosphate—ABL1—female gonad—uterine cancer	0.000139	0.00122	CbGeAlD
Adenosine triphosphate—ABL1—vagina—uterine cancer	0.000139	0.00122	CbGeAlD
Adenosine triphosphate—ABCC2—female reproductive system—uterine cancer	0.000133	0.00116	CbGeAlD
Adenosine triphosphate—ABL1—Epirubicin—Doxorubicin—uterine cancer	0.000132	0.042	CbGdCrCtD
Adenosine triphosphate—ABL1—Daunorubicin—Doxorubicin—uterine cancer	0.000132	0.042	CbGdCrCtD
Adenosine triphosphate—ABL1—Idarubicin—Doxorubicin—uterine cancer	0.000132	0.042	CbGdCrCtD
Adenosine triphosphate—ADK—lymph node—uterine cancer	0.000125	0.00109	CbGeAlD
Adenosine triphosphate—ABL1—lymph node—uterine cancer	8.97e-05	0.000786	CbGeAlD
Adenosine triphosphate—ABCB1—myometrium—uterine cancer	8.18e-05	0.000717	CbGeAlD
Adenosine triphosphate—ABCC2—lymph node—uterine cancer	7.75e-05	0.00068	CbGeAlD
Adenosine triphosphate—ABCB1—epithelium—uterine cancer	6.42e-05	0.000563	CbGeAlD
Adenosine triphosphate—ABCB1—uterine cervix—uterine cancer	6.36e-05	0.000558	CbGeAlD
Adenosine triphosphate—ABCB1—decidua—uterine cancer	6.06e-05	0.000532	CbGeAlD
Adenosine triphosphate—ABCB1—renal system—uterine cancer	5.95e-05	0.000522	CbGeAlD
Adenosine triphosphate—ABCB1—endometrium—uterine cancer	5.75e-05	0.000505	CbGeAlD
Adenosine triphosphate—ABCB1—mammalian vulva—uterine cancer	5.57e-05	0.000488	CbGeAlD
Adenosine triphosphate—ABCB1—uterus—uterine cancer	5.3e-05	0.000465	CbGeAlD
Adenosine triphosphate—ABCB1—female reproductive system—uterine cancer	4.77e-05	0.000418	CbGeAlD
Adenosine triphosphate—ABCB1—female gonad—uterine cancer	4.34e-05	0.00038	CbGeAlD
Adenosine triphosphate—ABCB1—vagina—uterine cancer	4.31e-05	0.000378	CbGeAlD
Adenosine triphosphate—ABCB1—lymph node—uterine cancer	2.79e-05	0.000245	CbGeAlD
Adenosine triphosphate—ADCY1—Disease—ERBB2—uterine cancer	5.67e-06	4.45e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—ESR1—uterine cancer	5.65e-06	4.43e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—PIK3CA—uterine cancer	5.65e-06	4.43e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—NRAS—uterine cancer	5.63e-06	4.42e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.63e-06	4.42e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—CTNNB1—uterine cancer	5.61e-06	4.4e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—HRAS—uterine cancer	5.58e-06	4.38e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—CTNNB1—uterine cancer	5.53e-06	4.34e-05	CbGpPWpGaD
Adenosine triphosphate—ACSS1—Metabolism—AKT1—uterine cancer	5.52e-06	4.33e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—VEGFA—uterine cancer	5.51e-06	4.33e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—AKT1—uterine cancer	5.5e-06	4.31e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MTHFR—uterine cancer	5.5e-06	4.31e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—CDKN1B—uterine cancer	5.48e-06	4.3e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—PTEN—uterine cancer	5.47e-06	4.29e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—TP53—uterine cancer	5.46e-06	4.29e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—PTEN—uterine cancer	5.46e-06	4.28e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—NRAS—uterine cancer	5.45e-06	4.27e-05	CbGpPWpGaD
Adenosine triphosphate—ADK—Metabolism—PIK3CA—uterine cancer	5.44e-06	4.27e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—EP300—uterine cancer	5.42e-06	4.26e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—ESR1—uterine cancer	5.41e-06	4.25e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—AKT1—uterine cancer	5.41e-06	4.24e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—VEGFA—uterine cancer	5.41e-06	4.24e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CCL2—uterine cancer	5.4e-06	4.23e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—PTEN—uterine cancer	5.39e-06	4.23e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—CTNNB1—uterine cancer	5.38e-06	4.22e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.37e-06	4.21e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—NRAS—uterine cancer	5.34e-06	4.19e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—NRAS—uterine cancer	5.34e-06	4.19e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Metabolism—PIK3CA—uterine cancer	5.27e-06	4.14e-05	CbGpPWpGaD
Adenosine triphosphate—ACSL1—Metabolism—PIK3CA—uterine cancer	5.27e-06	4.14e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—MTHFR—uterine cancer	5.27e-06	4.13e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—ESR1—uterine cancer	5.26e-06	4.13e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—CDKN1B—uterine cancer	5.25e-06	4.12e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—PTEN—uterine cancer	5.24e-06	4.11e-05	CbGpPWpGaD
Adenosine triphosphate—ACSS2—Metabolism—AKT1—uterine cancer	5.23e-06	4.1e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—HRAS—uterine cancer	5.22e-06	4.1e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—EP300—uterine cancer	5.21e-06	4.09e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—AKT1—uterine cancer	5.19e-06	4.07e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—CTNNB1—uterine cancer	5.18e-06	4.06e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—AKT1—uterine cancer	5.14e-06	4.03e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—EP300—uterine cancer	5.14e-06	4.03e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—STK11—uterine cancer	5.12e-06	4.02e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—NRAS—uterine cancer	5.12e-06	4.02e-05	CbGpPWpGaD
Adenosine triphosphate—ASNS—Metabolism—PIK3CA—uterine cancer	5.12e-06	4.02e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—CCL2—uterine cancer	5.1e-06	4e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	5.09e-06	3.99e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—NRAS—uterine cancer	5.07e-06	3.98e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—PTEN—uterine cancer	5.05e-06	3.96e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—EP300—uterine cancer	5e-06	3.92e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CCL2—uterine cancer	4.97e-06	3.9e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—CTNNB1—uterine cancer	4.96e-06	3.9e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—KRAS—uterine cancer	4.94e-06	3.88e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—NRAS—uterine cancer	4.88e-06	3.83e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—NRAS—uterine cancer	4.87e-06	3.82e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—KRAS—uterine cancer	4.85e-06	3.81e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—PTEN—uterine cancer	4.84e-06	3.8e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—EP300—uterine cancer	4.81e-06	3.78e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—NRAS—uterine cancer	4.81e-06	3.77e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—SOCS3—uterine cancer	4.8e-06	3.76e-05	CbGpPWpGaD
Adenosine triphosphate—ASS1—Metabolism—AKT1—uterine cancer	4.78e-06	3.75e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CCL2—uterine cancer	4.77e-06	3.74e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—KRAS—uterine cancer	4.69e-06	3.68e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—NRAS—uterine cancer	4.68e-06	3.67e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—GPCR downstream signaling—PIK3CA—uterine cancer	4.65e-06	3.65e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.64e-06	3.64e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—EP300—uterine cancer	4.61e-06	3.62e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—AKT1—uterine cancer	4.61e-06	3.62e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CDH1—uterine cancer	4.6e-06	3.61e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—MTHFR—uterine cancer	4.6e-06	3.61e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—KRAS—uterine cancer	4.6e-06	3.61e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—KRAS—uterine cancer	4.59e-06	3.61e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CDKN2B—uterine cancer	4.59e-06	3.6e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—NRAS—uterine cancer	4.5e-06	3.53e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—ERBB2—uterine cancer	4.5e-06	3.53e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—POLD1—uterine cancer	4.46e-06	3.5e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IGF1R—uterine cancer	4.46e-06	3.5e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—GPCR downstream signaling—PIK3CA—uterine cancer	4.46e-06	3.5e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—PIK3CA—uterine cancer	4.46e-06	3.5e-05	CbGpPWpGaD
Adenosine triphosphate—ADK—Metabolism—AKT1—uterine cancer	4.45e-06	3.49e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—CXCL8—uterine cancer	4.44e-06	3.48e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—KRAS—uterine cancer	4.4e-06	3.46e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—KRAS—uterine cancer	4.37e-06	3.43e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CDH1—uterine cancer	4.36e-06	3.42e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.32e-06	3.39e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—NRAS—uterine cancer	4.32e-06	3.39e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—TP53—uterine cancer	4.31e-06	3.38e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Metabolism—AKT1—uterine cancer	4.31e-06	3.38e-05	CbGpPWpGaD
Adenosine triphosphate—ACSL1—Metabolism—AKT1—uterine cancer	4.31e-06	3.38e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CXCL8—uterine cancer	4.27e-06	3.35e-05	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Metabolism—PIK3CA—uterine cancer	4.23e-06	3.32e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—PIK3CA—uterine cancer	4.22e-06	3.31e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—PIK3CA—uterine cancer	4.22e-06	3.31e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—HRAS—uterine cancer	4.2e-06	3.3e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—KRAS—uterine cancer	4.2e-06	3.29e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—KRAS—uterine cancer	4.19e-06	3.29e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—SMAD3—uterine cancer	4.19e-06	3.29e-05	CbGpPWpGaD
Adenosine triphosphate—ASNS—Metabolism—AKT1—uterine cancer	4.18e-06	3.28e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—AKR1C1—uterine cancer	4.18e-06	3.28e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CDKN1B—uterine cancer	4.17e-06	3.27e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—ERBB2—uterine cancer	4.14e-06	3.25e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—KRAS—uterine cancer	4.14e-06	3.25e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—HRAS—uterine cancer	4.12e-06	3.24e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—TP53—uterine cancer	4.09e-06	3.21e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—PTEN—uterine cancer	4.05e-06	3.18e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—PIK3CA—uterine cancer	4.05e-06	3.18e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—CXCL8—uterine cancer	4.03e-06	3.16e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—KRAS—uterine cancer	4.02e-06	3.16e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—PIK3CA—uterine cancer	4.01e-06	3.15e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—FGFR2—uterine cancer	4e-06	3.14e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—HRAS—uterine cancer	3.98e-06	3.13e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—ERBB2—uterine cancer	3.97e-06	3.12e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.97e-06	3.12e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CTNNB1—uterine cancer	3.94e-06	3.09e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CXCL8—uterine cancer	3.93e-06	3.08e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—HRAS—uterine cancer	3.91e-06	3.07e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—HRAS—uterine cancer	3.9e-06	3.06e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—ERBB2—uterine cancer	3.88e-06	3.05e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—KRAS—uterine cancer	3.88e-06	3.04e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—EP300—uterine cancer	3.86e-06	3.03e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—PIK3CA—uterine cancer	3.86e-06	3.03e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—PIK3CA—uterine cancer	3.85e-06	3.02e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.84e-06	3.02e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CDKN1B—uterine cancer	3.84e-06	3.01e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—PTEN—uterine cancer	3.84e-06	3.01e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—PIK3CA—uterine cancer	3.8e-06	2.98e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—GPCR downstream signaling—AKT1—uterine cancer	3.8e-06	2.98e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CXCL8—uterine cancer	3.77e-06	2.96e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—HRAS—uterine cancer	3.74e-06	2.94e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—RRM2—uterine cancer	3.72e-06	2.92e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—KRAS—uterine cancer	3.72e-06	2.92e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—HRAS—uterine cancer	3.71e-06	2.91e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—PTEN—uterine cancer	3.71e-06	2.91e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—PIK3CA—uterine cancer	3.7e-06	2.9e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—ERBB2—uterine cancer	3.68e-06	2.89e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CDKN1B—uterine cancer	3.68e-06	2.89e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—EP300—uterine cancer	3.66e-06	2.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—GPCR downstream signaling—AKT1—uterine cancer	3.64e-06	2.86e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CTNNB1—uterine cancer	3.63e-06	2.85e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—DCN—uterine cancer	3.61e-06	2.84e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CDKN1B—uterine cancer	3.6e-06	2.82e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—ERBB2—uterine cancer	3.59e-06	2.81e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—HRAS—uterine cancer	3.57e-06	2.8e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—HRAS—uterine cancer	3.56e-06	2.8e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—PIK3CA—uterine cancer	3.56e-06	2.79e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—EP300—uterine cancer	3.53e-06	2.77e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—PTEN—uterine cancer	3.53e-06	2.77e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—HRAS—uterine cancer	3.52e-06	2.76e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—AKT1—uterine cancer	3.52e-06	2.76e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CTNNB1—uterine cancer	3.48e-06	2.73e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—VEGFA—uterine cancer	3.46e-06	2.72e-05	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Metabolism—AKT1—uterine cancer	3.46e-06	2.71e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—AKT1—uterine cancer	3.45e-06	2.71e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—AKT1—uterine cancer	3.45e-06	2.71e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—NRAS—uterine cancer	3.42e-06	2.69e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—ESR1—uterine cancer	3.42e-06	2.68e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—HRAS—uterine cancer	3.42e-06	2.68e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—PIK3CA—uterine cancer	3.41e-06	2.68e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CDKN1B—uterine cancer	3.41e-06	2.68e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP11A1—uterine cancer	3.4e-06	2.67e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CTNNB1—uterine cancer	3.4e-06	2.67e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PTEN—uterine cancer	3.39e-06	2.66e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—EP300—uterine cancer	3.37e-06	2.65e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CDKN1B—uterine cancer	3.32e-06	2.61e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—PTEN—uterine cancer	3.31e-06	2.6e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—AKT1—uterine cancer	3.31e-06	2.59e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—HRAS—uterine cancer	3.29e-06	2.59e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.24e-06	2.55e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—NRAS—uterine cancer	3.23e-06	2.54e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—EP300—uterine cancer	3.23e-06	2.54e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CTNNB1—uterine cancer	3.22e-06	2.53e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—AKR1C3—uterine cancer	3.21e-06	2.52e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—VEGFA—uterine cancer	3.19e-06	2.51e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—EP300—uterine cancer	3.16e-06	2.48e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—HRAS—uterine cancer	3.16e-06	2.48e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—NRAS—uterine cancer	3.15e-06	2.47e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—AKT1—uterine cancer	3.15e-06	2.47e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PTEN—uterine cancer	3.14e-06	2.46e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CTNNB1—uterine cancer	3.14e-06	2.46e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—AKT1—uterine cancer	3.11e-06	2.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—VEGFA—uterine cancer	3.06e-06	2.4e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PTEN—uterine cancer	3.06e-06	2.4e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—NRAS—uterine cancer	3.02e-06	2.37e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—AKT1—uterine cancer	3.02e-06	2.37e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CCL2—uterine cancer	3.01e-06	2.36e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—EP300—uterine cancer	2.99e-06	2.35e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—NRAS—uterine cancer	2.95e-06	2.32e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—KRAS—uterine cancer	2.95e-06	2.31e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PTEN—uterine cancer	2.93e-06	2.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—EP300—uterine cancer	2.92e-06	2.29e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—AKT1—uterine cancer	2.91e-06	2.28e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—PIK3CA—uterine cancer	2.86e-06	2.24e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—PIK3CA—uterine cancer	2.82e-06	2.21e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—NRAS—uterine cancer	2.8e-06	2.2e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—EP300—uterine cancer	2.79e-06	2.19e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—AKT1—uterine cancer	2.79e-06	2.19e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—KRAS—uterine cancer	2.78e-06	2.18e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—NRAS—uterine cancer	2.73e-06	2.14e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—KRAS—uterine cancer	2.71e-06	2.13e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—PIK3CA—uterine cancer	2.71e-06	2.12e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TP53—uterine cancer	2.62e-06	2.05e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—PIK3CA—uterine cancer	2.61e-06	2.05e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—KRAS—uterine cancer	2.6e-06	2.04e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PTEN—uterine cancer	2.56e-06	2.01e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—PIK3CA—uterine cancer	2.56e-06	2.01e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—KRAS—uterine cancer	2.54e-06	2e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—ERBB2—uterine cancer	2.51e-06	1.97e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—STK11—uterine cancer	2.5e-06	1.97e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP19A1—uterine cancer	2.5e-06	1.97e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—HRAS—uterine cancer	2.5e-06	1.96e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—PIK3CA—uterine cancer	2.49e-06	1.96e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—EP300—uterine cancer	2.44e-06	1.92e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TP53—uterine cancer	2.41e-06	1.89e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—KRAS—uterine cancer	2.41e-06	1.89e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PIK3CA—uterine cancer	2.39e-06	1.88e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CXCL8—uterine cancer	2.38e-06	1.87e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—HRAS—uterine cancer	2.37e-06	1.86e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—KRAS—uterine cancer	2.35e-06	1.84e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—PIK3CA—uterine cancer	2.34e-06	1.83e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—AKT1—uterine cancer	2.34e-06	1.83e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CDKN1B—uterine cancer	2.33e-06	1.82e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TP53—uterine cancer	2.31e-06	1.81e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—HRAS—uterine cancer	2.31e-06	1.81e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PIK3CA—uterine cancer	2.21e-06	1.74e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—HRAS—uterine cancer	2.21e-06	1.74e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—AKT1—uterine cancer	2.21e-06	1.73e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CTNNB1—uterine cancer	2.2e-06	1.72e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HRAS—uterine cancer	2.16e-06	1.7e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PIK3CA—uterine cancer	2.16e-06	1.69e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PTEN—uterine cancer	2.14e-06	1.68e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—AKT1—uterine cancer	2.14e-06	1.68e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PIK3CA—uterine cancer	2.07e-06	1.62e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HRAS—uterine cancer	2.05e-06	1.61e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—EP300—uterine cancer	2.04e-06	1.6e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—AKT1—uterine cancer	2.04e-06	1.6e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—HRAS—uterine cancer	2e-06	1.57e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—AKT1—uterine cancer	1.95e-06	1.53e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—VEGFA—uterine cancer	1.93e-06	1.52e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—NRAS—uterine cancer	1.91e-06	1.5e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—MTHFR—uterine cancer	1.88e-06	1.48e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—AKT1—uterine cancer	1.81e-06	1.42e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PIK3CA—uterine cancer	1.81e-06	1.42e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—AKT1—uterine cancer	1.69e-06	1.32e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—KRAS—uterine cancer	1.64e-06	1.29e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PIK3CA—uterine cancer	1.51e-06	1.19e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TP53—uterine cancer	1.46e-06	1.15e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—HRAS—uterine cancer	1.4e-06	1.1e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PTEN—uterine cancer	1.05e-06	8.22e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—EP300—uterine cancer	9.98e-07	7.84e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PIK3CA—uterine cancer	7.39e-07	5.8e-06	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—AKT1—uterine cancer	6.03e-07	4.74e-06	CbGpPWpGaD
